The U.S. Patent and Trademark Office on Monday said it would review whether Harvard University and the Massachusetts Institute of Technology can claim rights to a gene-editing technology known as CRISPR, adding fuel to a rivalry between those institutions and the University of California.
Click here for original story, U.S. patent agency to review Harvard, MIT’s claim to CRISPR technology
Source: Reuters Science News